Influence of decalcification procedures on immunohistochemistry and molecular pathology in breast cancer
- 1 December 2016
- journal article
- research article
- Published by Elsevier in Laboratory Investigation
- Vol. 29 (12) , 1460-1470
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Discrepancies between primary tumor and metastasis: A literature review on clinically established biomarkersCritical Reviews in Oncology/Hematology, 2012
- Evaluating Methods for Isolating Total RNA and Predicting the Success of Sequencing Phylogenetically Diverse Plant TranscriptomesPLOS ONE, 2012
- Impact of Decalcification on Receptor Status in Breast CancerThe Breast Journal, 2011
- Influence of different decalcifying agents on EGF and EGFR immunostainingActa Histochemica, 2011
- Receptor conversion in distant breast cancer metastasesBreast Cancer Research, 2010
- American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast CancerJournal of Oncology Practice, 2010
- Discordance between core needle biopsy (CNB) and excisional biopsy (EB) for estrogen receptor (ER), progesterone receptor (PgR) and HER2 status in early breast cancer (EBC)Annals of Oncology, 2009
- Technical pitfalls potentially affecting diagnoses in immunohistochemistryJournal of Clinical Pathology, 2008
- Comparative Evaluation of Different DNA Extraction Procedures from Food SamplesBiotechnology Progress, 2007
- Influence of decalcifying agents on immunoreactivity of formalin-fixed, paraffin-embedded tissueJournal of Molecular Histology, 1984